CD11b (Mac-1) Antibody
- Known as:
- CD11b (Mac-1) Antibody
- Catalog number:
- MAB555C
- Product Quantity:
- 0.5 ml
- Category:
- -
- Supplier:
- INNOVEX
- Gene target:
- CD11b (Mac-1) Antibody
Related genes to: CD11b (Mac-1) Antibody
- Gene:
- ITGAM NIH gene
- Name:
- integrin subunit alpha M
- Previous symbol:
- CR3A, CD11B
- Synonyms:
- MAC-1, CD11b
- Chromosome:
- 16p11.2
- Locus Type:
- gene with protein product
- Date approved:
- 1988-08-05
- Date modifiied:
- 2019-04-23
Related products to: CD11b (Mac-1) Antibody
Related articles to: CD11b (Mac-1) Antibody
- Periodontitis (PD) and systemic juvenile idiopathic arthritis (sJIA) are chronic inflammatory diseases with potential clinical links, yet their shared molecular mechanisms remain unclear-patients with JIA face elevated periodontal risk, the temporomandibular joint affected in JIA shares inflammatory pathways with PD, Th17 cells drive both conditions, and glucocorticoid therapy may exacerbate periodontal vulnerability. This study aimed to explore the shared mechanisms and potential therapeutic targets of PD and sJIA using genetic expression data from the GEO database and performed comprehensive bioinformatics analyses, including differential expression gene analysis, weighted gene co‑expression network analysis (WGCNA), functional enrichment analysis, protein‑protein interaction network construction, and machine learning across 175 predictive models with the Ridge + AdaBoost ensemble identified as the best‑performing combination, followed by SHapley Additive exPlanations (SHAP) for model interpretability, CIBERSORT for immune infiltration assessment, and molecular docking with 100‑ns molecular dynamics simulations for therapeutic target validation. We identified 37 shared candidate genes between PD and sJIA, which were significantly enriched in IL‑17, NF‑κB, rheumatoid arthritis, and lipid atherosclerosis pathways, and machine learning screening further selected six core diagnostic genes (FAM46C, CXCL1, SELP, LGALSL, ELOVL4, VCAN), with SELP demonstrating the most robust cross‑model, cross‑dataset diagnostic value (AUC > 0.8); SHAP analysis confirmed SELP as a stable risk‑driving predictor across all models, while CXCL1 consistently showed protective effects. Immune infiltration revealed shared neutrophil elevation and CD8 ⁺ T‑cell reduction, with conserved CXCL1 and SELP correlations with neutrophils and resting mast cells, and FAM46C with plasma cells.Drug‑target network analysis identified IL1B, MMP1, and ITGAM as core targets, and molecular docking yielded strong binding affinities for deoxycholic acid-MMP1 (-7.6 kcal/mol), kaempferol-IL1B (-7.2 kcal/mol), kaempferol-ITGAM (-6.9 kcal/mol), with MD simulations confirming stable and specific binding. Collectively, this study explores shared genetic and immunological characteristics between PD and sJIA, suggests that SELP may serve as a critical cross‑disease diagnostic biomarker, and offers novel insights into their pathogenesis and potential therapeutic targets that warrant further experimental validation. - Source: PubMed
Publication date: 2026/09/23
Deng QingaoWang JunjieWang XingQi Lu - Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma that is histologically and clinically heterogeneous. Skeletonization is a computer vision technique used in image description, segmentation, and pattern recognition. - Source: PubMed
Publication date: 2026/09/01
Carreras JoaquimKikuti Yara YukieNagase ShunsukeRoncador GiovannaIkoma HarukaIto AtsushiOrita MakotoTomita SakuraTanigaki YukiUeno AkihisaKondo YusukeNakamura NaoyaMasugi Yohei - To develop an interpretable machine learning model based on Diffusion-Weighted Imaging (DWI) radiomics and D-dimer for 90-day outcome prediction after intravenous thrombolysis in acute ischemic stroke (AIS), and to explore candidate upstream transcriptional programs of D-dimer using publicly available rat middle cerebral artery occlusion (MCAO) datasets as an exploratory, hypothesis-generating step. - Source: PubMed
Publication date: 2026/08/28
Bai YupengLiu QifengZhan RuonanXu QiaoqiaoXia ChunhuaQian Yinfeng - Triple-negative breast cancer (TNBC) shows marked intratumoral heterogeneity and variable responses to neoadjuvant chemotherapy (NAC), but the cellular determinants of treatment response remain incompletely defined. - Source: PubMed
Publication date: 2026/08/19
Gao MenglongLiu ZhenXi LiliDuan HongliangGuo Jingjing - Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. Although immunotherapy has improved outcomes for a subset of patients, its limited efficacy in many cases highlights the need for a more comprehensive understanding of the CRC immune microenvironment. This study aimed to characterize the molecular landscape of the CRC immune microenvironment using an integrated multi-omics approach and to identify candidate regulatory molecules associated with immune remodelling. - Source: PubMed
Zeng HongweiLin LiewenChen YumeiXia LigangTang DongeDai YongZhang Wei